UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Immunotherapy for skin cancer

International immunology, 2019-07, Vol.31 (7), p.465-475

2019

Link zum Volltext

Verfügbarkeit prüfen

Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient

The Journal of experimental medicine, 2016-06, Vol.213 (7), p.1133-1139

2016

Link zum Volltext

Verfügbarkeit prüfen

Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype

Proceedings of the National Academy of Sciences - PNAS, 2012-03, Vol.109 (12), p.4592-4597

2012

Link zum Volltext

Verfügbarkeit prüfen

Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics

Journal of the American Academy of Dermatology, 2018-03, Vol.78 (3), p.457-463.e2

2018

Link zum Volltext

Verfügbarkeit prüfen

Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinoma

Heliyon, 2024-01, Vol.10 (1), p.e23521-e23521, Article e23521

2024

Link zum Volltext

Verfügbarkeit prüfen

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Nature medicine, 2019-07, Vol.25 (7), p.1064-1072

2019

Link zum Volltext

Verfügbarkeit prüfen

Age-Specific Incidence of Melanoma in the United States

JAMA dermatology (Chicago, Ill.), 2020-01, Vol.156 (1), p.57

2020

Link zum Volltext

Verfügbarkeit prüfen

Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma

Journal of investigative dermatology, 2021-08, Vol.141 (8), p.1897-1905

2021

Link zum Volltext

Verfügbarkeit prüfen

A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia

Blood, 2017-11, Vol.130 (22), p.2410-2419

2017

Link zum Volltext

Verfügbarkeit prüfen

Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients

Science translational medicine, 2013-02, Vol.5 (174), p.174ra27

2013

Link zum Volltext

Verfügbarkeit prüfen

T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression

Journal of clinical oncology, 2016-11, Vol.34 (31), p.3787-3795

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

Nature medicine, 2000-07, Vol.6 (7), p.762-768

2000

Link zum Volltext

Verfügbarkeit prüfen

The Anticancer Potential of T Cell Receptor-Engineered T Cells

Trends in cancer, 2021-01, Vol.7 (1), p.48-56

2021

Link zum Volltext

Verfügbarkeit prüfen

Re-adapting T cells for cancer therapy: from mouse models to clinical trials

Immunological reviews, 2014-01, Vol.257 (1), p.145-164

2014

Link zum Volltext

Verfügbarkeit prüfen

New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies

Clinical cancer research, 2015-12, Vol.21 (23), p.5191-5197

2015

Link zum Volltext

Verfügbarkeit prüfen

An In Vivo Model of Human Macrophages in Metastatic Melanoma

The Journal of immunology (1950), 2022-08, Vol.209 (3), p.606-620

2022

Link zum Volltext

Verfügbarkeit prüfen

Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistry

Journal of immunological methods, 2021-05, Vol.492, p.112955-112955, Article 112955

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8 + T Cells within Polyomavirus-Driven Merkel Cell Carcinomas

Cancer immunology research, 2020-05, Vol.8 (5), p.648-659

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Immunotherapy for skin cancer

Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient

Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype

Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics

Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinoma

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Age-Specific Incidence of Melanoma in the United States

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells

Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma

A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia

Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients

T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression

γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

The Anticancer Potential of T Cell Receptor-Engineered T Cells

Re-adapting T cells for cancer therapy: from mouse models to clinical trials

New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies

qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissue

Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8 + T cells in persons with previous COVID-19

An In Vivo Model of Human Macrophages in Metastatic Melanoma

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency

Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistry

Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8 + T Cells within Polyomavirus-Driven Merkel Cell Carcinomas

Suchergebnisse filtern